Platinum Partners Liquid Opportunity Master Fund L.P.'s Net Worth
$123 Million
Who is Platinum Partners Liquid Opportunity Master Fund L.P.?
Platinum Partners Liquid Opportunity Master Fund L.P. has an estimated net worth of $123 Million. This is based on reported shares across multiple companies, which include INDIA FUND INC, NAVIDEA BIOPHARMACEUTICALS, INC., and Echo Therapeutics, Inc..
SEC CIK
Platinum Partners Liquid Opportunity Master Fund L.P.'s CIK is 0001476165
Past Insider Trading and Trends
2010 was Platinum Partners Liquid Opportunity Master Fund L.P.'s most active year for acquiring shares with 6 total transactions. Platinum Partners Liquid Opportunity Master Fund L.P.'s most active month to acquire stocks was the month of November. 2010 was Platinum Partners Liquid Opportunity Master Fund L.P.'s most active year for disposing of shares, totalling 6 transactions. Platinum Partners Liquid Opportunity Master Fund L.P.'s most active month to dispose stocks was the month of November. 2010 saw Platinum Partners Liquid Opportunity Master Fund L.P. paying a total of $28,611,918.23 for 1,128,738 shares, this is the most they've acquired in one year. In 2010 Platinum Partners Liquid Opportunity Master Fund L.P. cashed out on 2,242,622 shares for a total of $86,345,831.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INDIA FUND INC (IFN) Snapshot price: $18
InvestorPlatinum Partners Liquid Opportunity Master Fund L.P. owns 3,669,283 units of Common Stock which is worth $66,047,094.00. In the year 2011 Platinum Partners Liquid Opportunity Master Fund L.P. filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.51% | -1.09M |
$36.08 | -$57,391,977.02 | 29.95M |
Dec 22 - Dec 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Snapshot price: $0.0251
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Echo Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -65.68% | -1.50M |
—
|
—
| 783.88K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| +10.73% | 65.74K |
$2.20 | $144,625.80 | 678.45K |
Jun 27 - Jun 30
| |||
Form 4
| +2.91% | 17.3K |
$2.20 | $38,060.00 | 612.71K |
Jun 25 - Jun 26
| |||
Form 4
| +2.93% | 16.96K |
$2.20 | $37,307.60 | 595.41K |
Jun 20 - Jun 24
| |||
Form 4
| +6.84% | 69.57K |
$2.75 | $191,314.75 | 1.09M |
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||